Cargando…
Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study
BACKGROUND: Management guidelines for chronic obstructive pulmonary disease (COPD) recommend that inhaled corticosteroids (ICS) are prescribed to patients with the most severe symptoms. However, these guidelines have not been widely implemented by physicians, leading to widespread use of ICS in pati...
Autores principales: | Price, David B., Russell, Richard, Mares, Rafael, Burden, Anne, Skinner, Derek, Mikkelsen, Helga, Ding, Cherlyn, Brice, Richard, Chavannes, Niels H., Kocks, Janwillem W. H., Stephens, Jeffrey W., Haughney, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033451/ https://www.ncbi.nlm.nih.gov/pubmed/27658209 http://dx.doi.org/10.1371/journal.pone.0162903 |
Ejemplares similares
-
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD
por: Ming, Simon Wan Yau, et al.
Publicado: (2020) -
Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG
por: Tsiligianni, Ioanna, et al.
Publicado: (2016) -
Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD
por: Westerik, Janine A. M., et al.
Publicado: (2017) -
Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study
por: Kostikas, Konstantinos, et al.
Publicado: (2020) -
Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG
por: Lisspers, Karin, et al.
Publicado: (2016)